基本再生数R0和有效再生数Rt有什么区别？
What is the difference between the basic reproduction number R0 and the effective reproduction number Rt?
R0指在完全易感、没有任何干预的人群中，一个感染者平均能传染的人数，是衡量病原体传播潜力的理论指标。Rt是特定时刻的实时再生数，已经包含了人群免疫水平、行为改变和防控措施的综合影响，Rt大于1提示疫情仍在扩大，小于1则趋于收缩，因此更适合用来评估干预效果。两者的估计都依赖代际间隔、报告延迟和检测覆盖等假设，需要随监测数据不断修正。
R0 is the average number of secondary cases one infectious person generates in a fully susceptible population with no interventions, a theoretical measure of transmission potential. Rt is the real-time reproduction number at a given moment and already reflects population immunity, behaviour change and control measures, so Rt above 1 indicates a growing epidemic and below 1 a shrinking one, making it the better gauge of intervention effect. Both estimates depend on assumptions about the generation interval, reporting delays and testing coverage, and must be revised as surveillance data accumulate.
难度 专业 · 适合 高中(15-18)
CC BY 4.0 · 已核验 · Verified 2026-08-23 · 2 条独立证据
来源 · Source
Harrison's Principles of Internal Medicine 第20版,McGraw-Hill,2018
J. Loscalzo et al., Harrison's Principles of Internal Medicine, 20th ed., McGraw-Hill, 2018
独立核验依据 · Independent verification: 核验依据 2 OPENLIBRARY ISBN 标识 9781259644047（按标识回读: Harrison's prin
#基本再生数 #有效再生数 #传播动力学
群体免疫阈值怎么估算？为什么麻疹需要约95%的接种率？
How is the herd immunity threshold estimated, and why does measles need about 95 percent coverage?
在人群均匀混合的简化模型中，阈值约等于1减去1除以R0，R0越大所需免疫人口比例越高。麻疹的R0通常估计在12至18之间，对应阈值约92%至94%，再考虑疫苗有效率不足百分之百和接触并非均匀，需要两剂接种率维持在95%左右才能阻断本地持续传播。现实中免疫水平在地区和人群之间分布不均，局部覆盖率下降就足以引发暴发，因此不能只看全国平均值。
In a simplified model of homogeneous mixing, the threshold is roughly one minus one divided by R0, so a higher R0 demands a larger immune fraction. Measles R0 is usually estimated at 12 to 18, giving a threshold near 92 to 94 percent, and once imperfect vaccine efficacy and non-uniform contact patterns are considered, two-dose coverage around 95 percent is needed to interrupt endemic transmission. Because immunity is unevenly distributed across regions and groups, local coverage gaps alone can spark outbreaks, so national averages can be misleading.
难度 专业 · 适合 高中(15-18)
CC BY 4.0 · 已核验 · Verified 2026-08-23 · 2 条独立证据
来源 · Source
Harrison's Principles of Internal Medicine 第20版,McGraw-Hill,2018
J. Loscalzo et al., Harrison's Principles of Internal Medicine, 20th ed., McGraw-Hill, 2018
独立核验依据 · Independent verification: 核验依据 2 OPENLIBRARY ISBN 标识 9781259644047（按标识回读: Harrison's prin
#群体免疫阈值 #麻疹 #疫苗覆盖率
「同一健康」（One Health）的核心思想是什么？
What is the core idea of the One Health approach?
同一健康强调人、动物和生态环境的健康彼此依存，需要跨部门协同治理。多数新发传染病源于动物，气候变化、土地利用改变、集约养殖和野生动物贸易都会提高病原体溢出风险，因此监测与防控必须把兽医、农业、林业环境和公共卫生系统连接起来。抗微生物药物耐药、食品安全和病媒传播疾病都是典型的同一健康议题。
One Health holds that human, animal and environmental health are interdependent and require coordinated action across sectors. Most emerging infectious diseases originate in animals, and climate change, land-use change, intensive livestock production and wildlife trade all raise the risk of pathogen spillover, so surveillance and control must link veterinary, agricultural, environmental and public health systems. Antimicrobial resistance, food safety and vector-borne diseases are classic One Health issues.
难度 进阶 · 适合 初中(12-15)
CC BY 4.0 · 已核验 · Verified 2026-08-23 · 2 条独立证据
来源 · Source
Harrison's Principles of Internal Medicine 第20版,McGraw-Hill,2018
J. Loscalzo et al., Harrison's Principles of Internal Medicine, 20th ed., McGraw-Hill, 2018
独立核验依据 · Independent verification: 核验依据 2 OPENLIBRARY ISBN 标识 9781259644047（按标识回读: Harrison's prin
#同一健康 #人畜共患病 #跨部门协作
mRNA疫苗平台为什么能快速应对新出现的病原体？
Why can the mRNA vaccine platform respond quickly to newly emerging pathogens?
mRNA疫苗只需病原体目标抗原的基因序列即可体外转录合成，不必培养病毒或纯化蛋白，更换序列时生产工艺和质量控制体系基本不变，因此从拿到序列到获得候选疫苗的时间被大幅压缩。新冠疫苗的三期试验证实了该平台的高保护效力，也验证了脂质纳米颗粒递送与核苷修饰技术的可行性。仍需解决冷链要求、成本与可及性，以及针对不同病原体的抗原设计难度等问题。
An mRNA vaccine only needs the gene sequence of the target antigen for in vitro transcription, so there is no need to culture virus or purify protein, and swapping sequences leaves manufacturing and quality control largely unchanged, which compresses the time from sequence to candidate vaccine. Phase 3 trials of COVID-19 vaccines demonstrated high efficacy for the platform and validated lipid nanoparticle delivery with nucleoside modification. Remaining challenges include cold chain requirements, cost and access, and the difficulty of antigen design for other pathogens.
难度 进阶 · 适合 大众
CC BY 4.0 · 来源待核验 · Source pending review
来源 · Source
出处备注：著录含书名，但缺版次 / 出版社 / 年份中的一部分，需编辑补全后才能做独立比对。
《新英格兰医学杂志》(NEJM)（Polack 等，BNT162b2 mRNA疫苗三期试验，2020）
NEJM (Polack et al., phase 3 trial of the BNT162b2 mRNA vaccine, 2020)
#mRNA疫苗 #平台技术 #快速响应
「疾病X」是什么？为什么要为还不存在的疾病做准备？
What is Disease X, and why prepare for a disease that does not yet exist?
疾病X是国际公共卫生机构在优先病原体清单中使用的占位概念，指某种目前未知、但有可能引起严重国际流行的病原体。把它写入清单的目的是推动通用性准备：可快速换抗原的疫苗与诊断平台、预先设计的临床试验主方案、覆盖面更广的基因组监测网络以及物资与人力应急机制。这样当新病原真正出现时，研发和响应不必从零开始。
Disease X is a placeholder used by international public health bodies in priority pathogen lists to denote an as-yet-unknown agent that could cause a serious international epidemic. Including it drives generic preparedness: vaccine and diagnostic platforms whose antigens can be swapped quickly, pre-agreed master protocols for clinical trials, broader genomic surveillance networks, and standing arrangements for supplies and staff. When a genuinely new pathogen appears, response and development then need not start from scratch.
难度 进阶 · 适合 大众
CC BY 4.0 · 已核验 · Verified 2026-08-23 · 2 条独立证据
来源 · Source
Harrison's Principles of Internal Medicine 第20版,McGraw-Hill,2018
J. Loscalzo et al., Harrison's Principles of Internal Medicine, 20th ed., McGraw-Hill, 2018
独立核验依据 · Independent verification: 核验依据 2 OPENLIBRARY ISBN 标识 9781259644047（按标识回读: Harrison's prin
#疾病X #大流行准备 #优先病原清单
为什么抗微生物药物耐药性被视为全球重大健康威胁？
Why is antimicrobial resistance regarded as a major global health threat?
全球疾病负担研究估计，每年有上百万人的死亡可直接归因于细菌耐药，另有数百万死亡与之相关，负担在医疗资源薄弱的地区尤其沉重。耐药使常见感染、外科手术、肿瘤化疗和重症救治的安全性明显下降，而新型抗菌药物的研发速度远落后于耐药演化。应对策略包括感染预防与疫苗接种、抗菌药物合理使用管理、耐药监测网络以及减少农业中的非治疗性使用。
Global burden studies estimate that over a million deaths each year are directly attributable to bacterial resistance, with several million more associated with it, and the burden falls hardest on health systems with fewer resources. Resistance makes common infections, surgery, cancer chemotherapy and intensive care markedly less safe, while development of new antibacterial drugs lags far behind the pace of resistance evolution. Responses include infection prevention and vaccination, antimicrobial stewardship, resistance surveillance networks, and curbing non-therapeutic use in agriculture.
难度 进阶 · 适合 初中(12-15)
CC BY 4.0 · 来源待核验 · Source pending review
来源 · Source
出处备注：此条未指向带版次的可引用著作（通识性内容、机构文件或未展开的英文书名），本库不提供独立书目出处；如需精确引用，需由编辑补全具体篇目与版次。
The Lancet（全球细菌耐药疾病负担研究，2022）
The Lancet (global burden of bacterial antimicrobial resistance study, 2022)
#抗微生物耐药 #疾病负担 #抗菌药物管理
疫苗为什么必须依赖冷链？热稳定疫苗为何重要？
Why do vaccines depend on a cold chain, and why do heat-stable vaccines matter?
疫苗中的蛋白抗原、减毒活病毒或mRNA在偏离规定温度时会变性或降解，导致接种后无法产生足够免疫保护，而这种失效通常从外观上看不出来，因此从生产到接种点必须全程温度监控。多数疫苗要求2至8摄氏度，部分mRNA疫苗需超低温保存，这在电力和交通条件薄弱地区是主要瓶颈。开发耐热配方、冻干制剂并配合温度指示标签，可以显著提高偏远地区的接种可行性和疫苗有效利用率。
Protein antigens, live attenuated viruses and mRNA in vaccines denature or degrade outside their specified temperature range, so immunisation may fail to induce adequate protection, and because such loss of potency is usually invisible, temperature must be monitored from manufacture to the point of use. Most vaccines require 2 to 8 degrees Celsius and some mRNA products need ultra-low temperatures, which is a major bottleneck where electricity and transport are unreliable. Heat-stable formulations, freeze-dried products and vaccine vial monitors substantially improve feasibility and reduce waste in remote settings.
难度 进阶 · 适合 初中(12-15)
CC BY 4.0 · 已核验 · Verified 2026-08-23 · 2 条独立证据
来源 · Source
Harrison's Principles of Internal Medicine 第20版,McGraw-Hill,2018
J. Loscalzo et al., Harrison's Principles of Internal Medicine, 20th ed., McGraw-Hill, 2018
独立核验依据 · Independent verification: 核验依据 2 OPENLIBRARY ISBN 标识 9781259644047（按标识回读: Harrison's prin
#冷链 #疫苗效力 #免疫规划